-
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Read articleDavid Dearnaley et al.
Here you can find a selection of peer-reviewed papers and scientific posters to enhance the
understanding of the clinical benefits of the Raypilot system.
David Dearnaley et al.
Let’s keep in touch